bluebird bio, Inc. (BLUE) Stock Price, News, Quote & History
Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing.
BLUE Stock Price | bluebird bio Inc. Stock Quote (U.S.
3 days ago · BLUE | Complete bluebird bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
bluebird bio Stock Price | BLUE Stock Quote, News, and History
The latest bluebird bio stock prices, stock quotes, news, and BLUE history to help you invest and trade smarter.
Should I buy bluebird bio (BLUE) - Zacks - Zacks Investment Research
3 days ago · Should I buy Bluebird Bio (BLUE)? Use the Zacks Rank and Style Scores to find out is BLUE is right for your portfolio.
Bluebird Stock Price Today | NASDAQ BLUE Live Ticker
Pro. Investing.com. Oct 10, 2024. Bluebird bio stock plunges to 52-week low of $0.46. In a stark reflection of investor sentiment, Bluebird bio Inc's stock has tumbled to a 52-week low, touching ...
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to …
Feb 24, 2023 · Bluebird (BLUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
bluebird bio (NASDAQ:BLUE) Stock, Analyst Ratings, Price Targets ...
bluebird bio (NASDAQ:BLUE) Stock, Analyst Ratings, Price Targets, Forecasts. bluebird bio Inc has a consensus price target of $4.64 based on the ratings of 15 analysts. The high is $13 issued by...
Why Is Bluebird Bio (BLUE) Stock Up 17% Today? - InvestorPlace
Apr 28, 2023 · Curative gene therapy specialist Bluebird Bio (NASDAQ: BLUE) popped up strongly amid a broadly positive Friday on Wall Street. Primarily, the enthusiasm centers on JPMorgan Chase’s Eric Joseph ...
Buy bluebird bio's Lovo-Cel As It Transforms Sickle Cell Disease ...
Nov 29, 2023 · bluebird bio specializes in gene therapies for severe genetic diseases and has 2 FDA-approved products. EV/Sales multiple appears cheap. Find out why BLUE stock is a Buy.
bluebird bio: A Risk Worth Taking (NASDAQ:BLUE)
Jul 12, 2023 · Summary. bluebird works as a biotech company developing curative gene therapies to save lives. Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows...